SXTP insider filings

60 DEGREES PHARMACEUTICALS, INC. — 27 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-06-15. Screen SXTP transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for SXTP between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — 60 DEGREES PHARMACEUTICALS, INC.

FiledFormInsiderReported transactionsSource
2026-06-154DOW GEOFFREY S — President and CEO, DirectorPurchase (P): 7,350 @ $1.38EDGAR
2025-12-164DOW GEOFFREY S — President and CEO, DirectorPurchase (P): 9,670 @ $0.80EDGAR
2025-12-124DOW GEOFFREY S — President and CEO, DirectorPurchase (P): 9,350 @ $0.95 · Purchase (P): 3,613 @ $0.92EDGAR
2025-09-154DOW GEOFFREY S — President and CEO, DirectorGrant/award (A): 7,201 @ $1.39EDGAR
2025-08-144Landon Kristen — Chief Operating OfficerGrant/award (A): 4,167 (derivative) @ $0EDGAR
2025-08-144Landon Kristen — Chief Operating OfficerGrant/award (A): 4,540 @ $0EDGAR
2025-06-094DOW GEOFFREY S — President and CEO, DirectorGrant/award (A): 4,376 @ $2.99EDGAR
2025-06-054XU CHERYL — DirectorPurchase (P): 3,000 @ $2.87 · Purchase (P): 2,000 @ $2.90EDGAR
2025-01-244DOW GEOFFREY S — President and CEO, DirectorGrant/award (A): 525,000 (derivative) @ $0EDGAR
2025-01-244MILLER TYRONE — CFOGrant/award (A): 75,000 (derivative) @ $0EDGAR
2025-01-214DOW GEOFFREY S — President and CEO, DirectorGrant/award (A): 14,394 @ $0EDGAR
2025-01-214MILLER TYRONE — CFOGrant/award (A): 11,626 @ $0EDGAR
2024-12-184XU CHERYL — DirectorPurchase (P): 2,500 @ $1.85 · Purchase (P): 2,500 @ $1.80 · Purchase (P): 1,500 @ $1.60 · Purchase (P): 1,500 @ $1.58 · Purchase (P): 1,500 @ $1.55 · Purchase (P): 1,500 @ $1.52 · +1 moreEDGAR
2024-12-094DOW GEOFFREY S — President and CEO, DirectorPurchase (P): 17,549 @ $1.11 · Purchase (P): 20,579 @ $1.20 · Purchase (P): 35,823 @ $1.27EDGAR
2024-11-214DOW GEOFFREY S — President and CEO, DirectorPurchase (P): 2,500 @ $0.90 · Purchase (P): 1,000 @ $0.92 · Purchase (P): 3,500 @ $0.91EDGAR
2024-09-114XU CHERYL — DirectorPurchase (P): 5,000 @ $1.70EDGAR
2024-05-214XU CHERYL — DirectorOption exercise (M): 2,000 @ $0.22 · Option exercise (M): 2,000 (derivative) @ $0EDGAR
2024-05-214TOOVEY STEPHEN — DirectorGrant/award (A): 4,000 @ $0.22 · Grant/award (A): 4,000 (derivative) @ $0 · Option exercise (M): 4,000 (derivative) @ $0EDGAR
2024-05-214MILLER TYRONE — CFOGrant/award (A): 60,000 @ $0.27 · Grant/award (A): 15,000 @ $0.22 · Grant/award (A): 75,000 (derivative) @ $0 · Option exercise (M): 60,000 (derivative) @ $0 · Option exercise (M): 15,000 (derivative) @ $0EDGAR
2024-05-214FIELD PAUL — DirectorOption exercise (M): 4,000 @ $0.22 · Grant/award (A): 4,000 (derivative) @ $0 · Option exercise (M): 4,000 (derivative) @ $0EDGAR
2024-05-214DOW GEOFFREY S — President and CEO, DirectorOption exercise (M): 68,000 @ $0.27 · Option exercise (M): 17,000 @ $0.22 · Grant/award (A): 85,000 (derivative) @ $0 · Option exercise (M): 68,000 (derivative) @ $0 · Option exercise (M): 17,000 (derivative) @ $0EDGAR
2024-05-214Allen Charles W — DirectorOption exercise (M): 4,000 @ $0.22 · Grant/award (A): 4,000 (derivative) @ $0 · Option exercise (M): 4,000 (derivative) @ $0EDGAR
2024-04-034Knight Therapeutics Inc
KNIGHT THERAPEUTICS INTERNATIONAL SA
Conversion (C): 45,560 @ $4.75 · Conversion (C): 2,162 @ $0EDGAR
2024-02-024DOW GEOFFREY S — President and CEO, DirectorPurchase (P): 25,974 @ $0.38 · Purchase (P): 25,974 (derivative) @ $0.01EDGAR
2024-02-024XU CHERYL — DirectorPurchase (P): 200,000 @ $0.38 · Option exercise (M): 2,000 · Purchase (P): 200,000 (derivative) @ $0.01EDGAR
2023-07-124MILLER TYRONE — Chief Financial OfficerGrant/award (A): 240,000 (derivative) @ $0EDGAR
2023-07-124DOW GEOFFREY S — President and CEO, Director, 10% ownerGrant/award (A): 300,000 (derivative) @ $0EDGAR

Recent 8-K events — 60 DEGREES PHARMACEUTICALS, INC.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-208-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
7.01 — Regulation FD Disclosure
8.01 — Other Events
EDGAR
2026-11-068-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-278-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-238-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-068-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-148-K8.01 — Other EventsEDGAR
2026-09-088-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-068-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-08-048-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-208-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=SXTP returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs